SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Manny Gugliuzza who wrote (998)7/30/1998 10:24:00 AM
From: Emec  Read Replies (1) | Respond to of 1510
 
Soon, shorts will get the life squeezed out of them. I will enjoy watching it. I know Jake, vicious aren't I?



To: Manny Gugliuzza who wrote (998)7/31/1998 10:04:00 PM
From: Robert DeHaven  Read Replies (2) | Respond to of 1510
 
Manny: I have started buying again...a while back a fund manager told me why IMNR should trade on or around 10...that is until it get its approval for Remune....I guess we are back where we started.

Now is different the short interest is simply reckless....The sheep have piled in and the flock mentality of free money is seldom right. This is a bear trap. Just need to set it off...

good luck,

bob


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News